CMA Microdialysis is a Swedish life science research tools company founded in 1984 as a spin-off from the Karolinska Institute. CMA’s complete lines of instruments and consumables are used globally by universities and pharmaceutical companies as unique tools in pre-clinical research.
The concept of Microdialysis was born in the early 1970's. While examining the cross-section of a blood vessel among nerve endings and in order to monitor the chemical events in the tissue; Professor Urban Ungerstedt of the Karolinska Institute in Stockholm had the idea of using a dialysis tube as "an artificial blood capillary".
The first paper on Microdialysis was published in 1974. Since then, more than 13.000 scientific papers have been published on the technique.
CMA´s vision is: To substantially shorten the time-to-market of drug and research projects by offering a complete and leading portfolio of Microdialysis products.
Microdialysis
Microdialysis is a unique technique to monitor the chemistry of the extracellular space in living tissue. In basic research it is primarily used for In Vivo determinations of endogenous compound changes in the Central nervous system. Microdialysis has also found important application in peripheral tissues; primarily in drug delivery, pharmacokinetics, bioavailability and bioequivalence.
Company Details
- Founded
- -
- Industry
- Medical Device
- Website
- microdialysis.se
- Keywords
- Microdialysis.
Cma Microdialysis Ab Questions
Cma Microdialysis Ab's website is microdialysis.se
Cma Microdialysis Ab's LinkedIn profile is https://se.linkedin.com/company/cma-microdialysis-ab
Cma Microdialysis Ab's industry is
Medical Device
Cma Microdialysis Ab's top competitors are
Pronexus Analytical Ab,
Agnthos,
Release Finans,
Humly,
Quinyx,
Berger Könyvelőiroda,
Business Sweden,
Phenomenex,
Harvard Bioscience,
Alfvén & Didrikson.
Cma Microdialysis Ab's categories are Medical Device
Cma Microdialysis Ab's founding year is 1984
